Author guidelines
1.1 Essential Information
– Articles must be submitted to the journal’s online peer review system by the corresponding author.
– An anonymous version of your article should be submitted along with a separate title page.
– All authors, their affiliations, ORCIDs and disclosure statements should be included on a separate title page. Please see a template for the title page and disclosure statements required here.
– All articles must be submitted with a completed ICJME form from all authors.
– All article types (excluding invited editorials and letters to the editor) must include an abstract and keywords (min 3 – max 7).
– Articles must be submitted in Word.doc format and set up with continuous line numbering, double line spacing and page numbers. Please see the article body template here.
– Figures and tables:
- 1. No more than 5 figures and tables in total.
- 2. Additional figures/ tables, and those that fill more than 2 pages, should be marked as supplementary material.
- 3. Should appear at the end of the article, not embedded in the text.
- 4. Must include a figure/table title of no more than 100 characters.
- 5. Each figure/table must be referred to within the manuscript
- 6. Figures uploaded as image files
- 7. Any videos must be supplied as a URL link only.
– References:
- 1. Must be cited within the text body and appear in numerical order of the first mention.
- 2. List the first three authors only, followed by et al., unless there are four authors, in which case list all four.
- 3. Must include DOI and PubMed ID.
– AER and JAPSC only: For all original research, review articles and case reports, authors must include a (bulleted) ‘Clinical Perspective’ statement.
– Original Research articles must include:
- 1. Background
- 2. Methods
- 3. Results
- 4. Discussion
- 5. Study limitations
- 6. Conclusion
- 7. Trial Registration
- 8. Data availability statement
– Original Research and Case Reports must include a statement that written informed consent was obtained if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed.
– From 1 April 2022, Original Research must include a Data Access Statement even where no data is associated with the article or the data are inaccessible. Please choose an appropriate statement to accompany your submission.
– Word limits:
| Article Type | Abstract | Word Limit (words) | References |
|---|---|---|---|
| Case Report | 120 – 160 words (unstructured) | 1,500 – 3,000 | Max 50 refs |
| Editorial (invited only) | N/A | 1,500 – 2,000 | Max 15 refs |
| Expert Opinion | 120 – 160 words (unstructured) | 1,500 – 2,500 | Max 20 refs |
| Letter to Editor | N/A | Up to 1,500 | Max 10 refs |
| Original Research | 250 words (structured) | 2,500 – 5,000 | Max 100 refs |
| Review Article | 120 – 160 words (unstructured) | 2,500 – 5,000 | Max 80 refs |
– Authors must accept the OA T&Cs in the submission questionnaire.
– Non-native English? Make sure you have considered a language edit prior to submission.
1.2 Summary
Vascular and Endovascular Review (VER) endeavour to publish unbiased content. All articles must be of an impartial nature.
All submissions are subject to independent, double-blind peer review and are copyedited prior to publication. The Editors-in-chief with the support of the handling editor will oversee the peer review process and the editor-in-chief will make the final decision on the submission’s suitability for inclusion.
Articles must be submitted using our electronic peer review system,
https://verjournal.com/submissions/index.php/ver/login
1.3 Why Publish with Us?
Vascular and Endovascular Review (VER) aims to support the continuous medical education of both specialist and general cardiologists. We publish balanced and comprehensive articles written by leading authorities, addressing the most pertinent developments in their field. Our authors benefit from:
Open research
All research published in our portfolio of journals is open access which means the version of record (VOR) is freely accessible to everyone across the globe immediately upon publication. As an author you retain all non-commercial rights for articles published under the Creative Commons Attribution Non-commercial CC-BY-NC 4.0 license, allowing users to read, download, copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
Quality
We are committed to the highest standards of peer review. All of our journals follow a rigorous double-blind peer-review process that is conducted independently and treated confidentially. All articles and the peer review comments received are evaluated by the Editor-in-Chief before they make their decision.
Speed
On average, articles submitted to our journals receive their first decision in 5 weeks of submission, ensuring rapid review while maintaining high-quality, rigorous peer review.
Visibility
In order to maximise the reach and impact of your research, we are committed to ensuring every article we publish is promoted as widely as possible. Along with open access, which supports increased readership and citations with no barriers to access, our marketing team with their SEO expertise, will ensure your research is visible to the widest possible audience, including marketing through our social and email channels to our global community of 158,000+ registered recipients.
Indexing
The journal is listed in Scopus and the Directory of Open Access Journals (DOAJ)
If you are interested in submitting an article, please visit the journal’s Author Guidelines page for more information.
2.0 Authorship
2.1 Authorship Criteria
All authors are automatically emailed at the submission to ensure they are aware of and approve the submission of the manuscript, its content and authorship.
All authors that meet the conditions for authorship as indicated below (based on the ICMJE criteria) should be listed and are accountable for the content should it be published. Authors must meet all four of the following conditions to qualify for authorship:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and
- Drafting the work or revising it critically for important intellectual content; and
- Final approval of the version to be published; and
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Those meeting the above criteria are eligible to participate in reviewing and drafting the final manuscript. The corresponding author will be responsible for key communication with the publisher. Those not meeting the above criteria should be acknowledged as a contributor in the acknowledgements section rather than as an author. The Publisher is not held responsible for identifying authors on the manuscript. This information must be supplied at submission.
2.2 Author Contributions
For original research submissions, the contributions of all authors must be described using the CRediT Taxonomy to describe the individual contributions. We expect that all authors will have reviewed and agreed to their contributions prior to submission and that they will accurately reflect their work.
- Conceptualisation: Ideas; formulation or evolution of overarching research goals and aims.
- Data curation: Producing metadata, scrubbing data and maintaining research data (including software code, where it is necessary for interpreting the data itself) for initial use and later reuse.
- Formal analysis: Application of statistical, mathematical, computational, or other formal techniques to analyze or synthesize. study data.
- Funding acquisition: Acquisition of the financial support for the project leading to this publication.
- Investigation: Conducting a research and investigation process, specifically performing the experiments, or data/evidence collection.
- Methodology: Development or design of methodology; creation of models.
- Project administration: Management and coordination responsibility for the research activity planning and execution.
- Resources: Provision of study materials, reagents, materials, patients, laboratory samples, animals, instrumentation, computing resources, or other analysis tools.
- Software: Programming, software development; designing computer programs; implementation of the computer code and supporting algorithms; testing of existing code components.
- Supervision: Oversight and leadership responsibility for the research activity planning and execution, including mentorship external to the core team.
- Validation: Verification, whether as a part of the activity or separate, of the overall replication/reproducibility of results/experiments and other research outputs.
- Visualisation: Preparation, creation and/or presentation of the published work, specifically visualization/data presentation.
- Writing – original draft preparation: Creation and/or presentation of the published work, specifically writing the initial draft (including substantive translation).
- Writing – review & editing: Preparation, creation and/or presentation of the published work by those from the original research group, specifically critical review, commentary or revision – including pre- or post-publication stages.
3.0 Manuscript Preparation
3.1 Submission Types
Articles accepted for publication include the following content types and may be solicited or unsolicited:
| Content Type | Description | Keywords | Word limits (excluding references/abstract) | Misc. | Figs | Tables | Videos | Clinical perspectives | Accepted in journals? |
| Case report | Present novel findings or strategies on a particular topic to aid diagnosis/treatment/management | 3 – 7 | 1500 – 3000
Max. 50 refs | Abstract to be supplied (120-160 words) |  | | | | VER, ICR3, JAPSC, USC |
| 300dpi
Max. 5 tif,.pdf or .jpeg format | |||||||||
| Editorial
*by invitation only | An article that reflects on a particular issue, event, methodology, innovation or gap in literature. | 3 – 7 | 1500 – 2000
Max. 15 refs | Not subject to peer-review | | | |  | All Journals |
| 300dpi
Max. 5 tif,.pdf or .jpeg format | |||||||||
| Expert opinion | Coverage of topical issues in cardiology from expert in field that will be of interest to readers | 3 – 7 | 1500 – 2500
Max. 20 refs | Accompanied by an abstract (120-160 words) | | | | | All Journals |
| 300dpi
Max. 5 tif,.pdf or .jpeg format | |||||||||
| Letter to editor | Readers are invited to provide comment on articles for the EiC to read/respond. | 3 – 7 | 1500
Max. 10 refs | Not subject to peer-review | | | | | All Journals |
| Review article | Summary and critical evaluation of current research/literature in the field and impact on current and future practice. | 3 – 7 | 2500 – 5000
Max. 80 refs | Accompanied by an abstract (120-160 words) | | | |
Required in AER, optional for others | All Journals |
| 300dpi
Max. 5 tif,.pdf or .jpeg | |||||||||
| Original
Research | Including clinical research and translational science | 3 – 7 | 2500 – 5000
Max. 100 refs | Accompanied by a structured abstract
(max 250 words) | | | |
Required | CFR, ECR, ICR, JAPSC, USC |
| 300dpi
Max. 5 tif,.pdf or .jpeg | |||||||||
| Short Communication | Concise report presenting original and significant findings on a particular topic of interest. | 3 – 7 | 1000
Max. 10 refs | Unstructured abstract (120 words) | | | |
Required | JAPSC, VER |
| Systematic Review | Including meta-analyses | 3 – 7 | 2500 – 5000
Max. 100 refs | Accompanied by a structured abstract
(max 250 words) | | | |
Required | AER, ECR, ICR, USC |
| 300dpi
Max. 5 tif,.pdf or .jpeg | |||||||||
3.2 Checklist Summary
| Section | Requirement | |
| Publication status | Submissions should not already be submitted for consideration elsewhere nor have previously been published. | |
| Pre-submission Language Editing | Authors may choose to use a professional language-editing service before submitting to the journal, particularly if English is not their first language. This is optional and does not guarantee that the submission will be accepted as final decisions will be based on peer review. It may help to ensure that your manuscript is clear to reviewers and journal editors. | |
| Submission types |
Articles submitted with word counts exceeding the limit will either be returned for reduction by the author or be reduced in length by the editor. | |
| General formatting |
| |
| Title page | Full title: of the article (<300 characters);
Short title (<75 characters); Author(s) information: full name, department, primary institution and/or organisation, city, state, country, full contact information: email addresses for all authors and one postal correspondence address for the lead author, including street and postcode. We also encourage ORCID identification to be listed. Abstract: (<160 words) Keywords: a minimum of 3 and a maximum of 7 keywords to be listed Disclosures: a statement of disclosure/conflicts of interest relevant to the article for each author; these must be supplied with a Disclosure of Conflicts of Interest form, this is mandatory: www.icmje.org/conflicts-of-interest Informed Consent to Participate and Publish (if applicable): Data Availability Statement (if applicable): Ethics approval statement (if applicable): Clinical Trial Registration (for clinical trials only): Provide the registry site and identifier number. Funding (optional): include grant numbers for funders if available. Support statements: include equipment, drugs, and /or other support that facilitated the conduct of the work Acknowledgements (optional): Author Contributions: (optional). See here for information on the presentation. Correspondence details: (include the full postal address of the corresponding author institution) Word count: should be provided for the article and should not include the abstract or references A downloadable template is available here. | |
| Abstract | Reviews, Expert Opinions and Case Reports:
Unstructured, unreferenced. Provides the context of the article. Should summarise the purpose, basic procedure, main findings and key conclusions. <160 words Original Research: Structured including the following headings:
The abstract should present essential data in 5 paragraphs. Use complete sentences. All data in the abstract also must appear in the manuscript text or tables. < 250 words | |
| Keywords | Capture the essence of your paper and help others to find the content.
A minimum of 3 and a maximum of 7 keywords are to be listed 1. Write a list of key phrases you believe HCPs would type into a search engine when trying to find content such as yours. 2. Group these words into logical themes. 3. Write semantic keywords that could be used as alternatives across themes. 4. Try to include both keywords and semantic keywords into the content but only if the keywords can be inserted in a way that will be natural to your writing. 5. Include keywords in the title of your work: use one or two of the words you believe are the most popular, whilst also highly relevant to your content. 6. If you have questions about keywords, please speak to your editor for assistance. | |
| Conflicts of interest/disclosures | The author(s) should state any conflicts of interest/intellectual property to the article, including any sources of financial support or assistance for work; ensure sponsor names/sponsoring organizations are included and the for-profit interest(s) the sponsor represents, if applicable.
Ensure to highlight if authors had access to the study data. Ensure a completed form from the ICMJE for disclosures, is completed by all authors and uploaded with the submission. We make it clear when any research has been funded. If a funded paper, please include the statement: Authors had full access to all data in this study and take full responsibility for the integrity of the data and the accuracy of the data analysis. | |
| Informed consent | Authors should include a statement in the manuscript that written informed consent was obtained if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed. Please see Section 3.6 for details of our Informed Consent Policy and sample statements. | |
| Data Availability Statement | Include a data availability statement (DAS) that links to your data. Where the data cannot be shared, you should confirm why it is not possible to share the data within this statement. Please see Section 4.10 for full details of our Data Sharing Policy. | |
| Patient and Public Involvement Statement | When reporting patient and public involvement in research, please address the following, tailored as appropriate for the study design reported:
1. Stage in the research process where patients/the public we involved and how. 2. How their priorities, experience and preferences were used to develop and inform the research questions(s) and outcome measures. 3. How they were involved in the design of this study? 4. How they were involved in the recruitment to and conduct of the study? 5. State if they were asked to assess the burden of the intervention and the time required to participate in the research. 6. How/will they be involved in the dissemination of the study results to participants and relevant wider patient communities (e.g by choosing what information/results to share, when and in what format)? If patients were not involved, please clearly state this. | |
| Ethics/Declaration of Helsinki | The authors should state that their study complies with the Declaration of Helsinki, that the locally appointed ethics committee has approved the research protocol and that written informed consent has been obtained from the subjects (or their legally authorised representative). | |
| Acknowledgements | The author(s) should acknowledge substantive contributions to the article, including assistance, advice, materials and other resources. | |
| Layout |
| |
| Language | All articles should be written in UK English, free from jargon, and the writing should be clear and direct. [note: USC Journal uses US English].
All acronyms and abbreviations must be explained in full at first mention. | |
| Figures, tables, illustrations, screenshots and photographs | 1. A maximum of five may be included. Anything over this amount should be supplied as supplementary data. In addition, any Tables that require more than 2 pages, must be supplied as supplementary material.
2. Digital files must be supplied as (.tiff, .pdf or .jpeg files) and be at least 300 dpi. Original figures may be redrawn as necessary. 3. Clear and concise titles must be provided, and all symbols and abbreviations used must be defined in a footnote. Detailed captions underneath figs/tables are optional. 4. All figures must be referred to in the main text and numbered sequentially. Figures submitted as supplementary material should start their numbering at 1. 5. Figure and table legends must be included in the manuscript after the reference section 6. All abbreviations used must be defined and spelt out in full in the caption. 7. High-resolution images are to be provided at revision stages if not supplied at submission. Tables: 8. Graphs and tables must be supplied as editable files formatted as a table in Microsoft Word or Excel. 9. To be added after the reference list. Authors are responsible for obtaining permission for all copyrighted material, including tables, figures and images. Please provide licences with submission. | |
| Videos | Videos may be published in the online article with a still image of the video in the print file/PDF. Videos must be submitted in mp4 or avi format. Please ensure the video is accurately labelled. Any additional videos submitted but not included in the main article may appear as supplementary data. | |
| References | In-text: All articles must be fully referenced
References must be numbered in order of the first mention. They must be indicated in the text by a superscript number with the full list at the end of the article in numerical/chronological order. Include the first three authors only, followed by et al., unless there are four authors, in which case list all four. Authors must include DOI and PubMed ID. (PubMed IDs can often be imported simply and quickly using software such as EndNote which most institutions have access to.) Examples: Journal article: Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008;1:209–18. https://doi.org/10.1161/CIRCEP.107.748103; PMID: 19122847. Book Chapter: Mansbach H. Sumatriptan: looking back and looking forward. In: Humphrey P, Ferari M, Olesen J (eds). The Triptans. New York: Oxford University Press, 2001;183–9. | |
| Supplementary Data | Supplementary material may be submitted to the journal if it is necessary to the integrity and excellent of the manuscript. It may take the form of figures, tables, datasets, videos, slide sets, formulas, podcasts etc. The supplementary material must be submitted at the time of manuscript submission as a separate file and will be published as a pdf file (unless in audio or video format). Supplementary figs/tables should be numbered sequentially starting from 1. and should not follow on numbering from the main manuscript.
Please note: Supplementary material will be subject to the same peer-review standards as the manuscript but will not be edited by the journal staff. Therefore, please take care to ensure that supplementary content is labelled and presented correctly, that grammar is corrected and that the journal style is followed throughout, especially in the references. Supplementary references must be cited in the main article and referenced at the end of the manuscript/acknowledgements. | |
| Permissions | Authors are responsible for obtaining permission for all copyrighted material, including tables, figures and images. Permission is required irrespective of ownership. Permission proof is required at the time of submission. Papers cannot be accepted for publication until all necessary permissions are obtained. | |
| Ethical Resources | When preparing your manuscript, we recommend you consult the following resources to improve the quality of your submission:
|
3.4 Permissions
If a figure, table or illustration has been previously published, please ensure the original source is acknowledged as a figure legend and written permission from the copyright holder is sought. All figures/tables must have one of the below statements if they are not original:
If it is data taken from and no permissions are required – Data from: XXX et al. YEAR,RefXXX et al. YEAR,RefXXX et al. YEAR.Ref
If it is reproduced – Source: XXX et al. YEAR.Ref Reproduced with permission from PUBLISHER.
If it is adapted – Source: XXX et al. YEAR.Ref Adapted with permission from PUBLISHER.
Original images that are the authors own and that have not been published elsewhere, do not require permission. If applicable, please indicate this as a legend in your submission. If all images are original, please include a statement to this effect in the manuscript/at submission.
Our journals are open access. Please ensure that open access reuse permission is sought where possible. If it if not, please highlight this by adding ‘This content is not covered by the Creative Commons license of this publication. To reuse, please contact the rights holder.’
Authors are responsible for obtaining permission for all copyrighted material, including tables, figures and images. Permission is required irrespective of ownership. Permission proof is required at the time of submission. Papers cannot be accepted for publication until all necessary permissions are sought.
3.5 Declarations: Conflict of Interest and Intellectual Property
A conflict of interest exists when an opinion may be influenced or biased by a secondary interest such as financial gain. Conflicts of interest may occur from commercial or financial interests and/or personal relationships, beliefs and or rivalries such as research funding, consultancy services, serving on speakers’ bureaus, travel expenses, appearance fees, the receipt of share options, or direct employment by a commercial entity.
Our publications make it clear where any conflicts of interest occur and inform readers when research has been funded. All authors, peer reviewers, editors and editorial board members must declare any conflicts of interest pertaining to the article when submitting a manuscript. All sources of support for the work where a conflict exists will be publicised. Conversely, please state clearly should there be no conflicts of interest to declare.
Reviewers must declare any conflicts of interest before conducting a peer review of a manuscript. Reviewers should decline to review if a potential conflict of interest is present. Editorial staff employed by Vascular and Endovascular Review (VER), editors-in-chief, guest editors and editorial board members, will not handle manuscripts where a potential conflict of interest or competing interest exists and will be excluded from the peer-review process.
Editorial members and guest editors may submit to the Journal and are not given any priority over other manuscript submissions. Articles authored by any in-house Editorial Board members will be treated with the same rigorous peer-review rules and handled avoiding any potential conflicts of interest. Where an author is a guest editor or editorial board member, this must be declared using one of the following statements in the submitted manuscript: [Author initials], is on the [insert journal name] editorial board; this did not influence peer review. For multiple editorial board members: [Author initials], is a/an [insert role] and [Author initials] is on the [insert journal name] editorial board; this did not influence peer review. [unless they have other COIs, in which case these shall be listed and added to the individual COIs]
All authors must complete the ICMJE disclosure form following this link. This must then be uploaded as an additional file, along with the manuscript submission. [Updated 04.03.22] Please note, this is now a mandatory requirement under our policy.
The questions asked in our electronic submission system (Editorial Manager) regarding disclosures, follows the ICMJE recommendations. These answers will be stored, and a disclosure statement will appear on every manuscript published within the journal based on your response. The purpose of this statement is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work.
Acknowledgements: The author(s) should acknowledge substantive contributions to the article, including receipt of financial assistance, materials and other resources.
Informed consent: Authors must ensure that manuscripts involving human subjects have written informed consent from the individual(s) involved and must ensure they provide consent to be involved in/aware of the planned publication as soon as possible. “Consent” refers to the consent to publish an individual’s personal information. You should make sure that the original copy of informed consent is held by the treating institution should any queries be raised in the future.
Informed consent must be given voluntarily, with free will and under no coercion and bribery of any kind. Authors should include a statement in the manuscript that written informed consent was obtained if experimentation/transplantation with human subjects was conducted. This applies even if the participant is deceased.
The privacy rights of human subjects must always be observed and steps should be taken to anonymise information that can identify a patient. Examples of identifying information include individual case histories, photos, x-rays or genetic phenotypes.
For more information please read the Nuremberg Code and the Belmont Report.
The table below provides some template statements that you may use or adapt. You can find further guidance on how to compose this statement on the ICMJE recommendations website.
| Type | Template statement: Consent to Participate |
| For Adults | Written informed consent was obtained from all individuals included in the study. |
| For Children | Written informed consent was obtained from all legal guardians OR Written informed consent was obtained from the parents. |
| For a particular figure | The authors affirm that human research participants provided written informed consent for the publication of the images in Figure(s) xx. |
| Additional statement if identifying information is included | Additional written informed consent was obtained from all individual participants for whom identifying information is included in the article. |
| Type | Template Statement: Consent to Publish |
| Consent to Publish | Patients provided written informed consent regarding publishing their data and photographs. |
Ethics approval, human and animal rights: If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out following the Code of Ethics of the World Medical Association (Declaration of Helsinki) for research involving humans or the EU Directive 2010/63/EU for animal experiments and/or ARRIVE guidelines for animal research.
| Research Type | Template statement: |
| Human | This study was carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki). Approval was granted by the Ethics Committee of [insert name]. |
| Animal | This study was approved by the [insert name] animal ethics committee and was carried out in accordance with the appropriate guidelines. |
| Observational Study | This is an observational study. The [insert name] Research Committee has confirmed that no ethical approval is required. |
3.6 References
All articles must be fully referenced following the Vancouver referencing style. References must be numbered in order of the first mention and must not be used to promote self-interests.
In-text citations
In-text citations must be indicated in the text as superscript, without parentheses and should appear after punctuation at the end of a sentence with no space preceding. Use commas between numbers and en-dashes between ranges. List references by a number with the full list at the end of the article in numerical order.
Journal Articles
Journal abbreviations are used as per Medline. If there are more than three authors, list the first three followed by et al., unless there are four authors, in which case list all four. Details should be ordered as: Surname Initials. Article title. Journal name year;volume:page numbers. doi: [doi number]. PMID: [PMID number].
Example: Delpón E, Cordeiro JM, Núñez L, et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008;1:209–18. https://doi.org/10.1161/CIRCEP.107.748103; PMID: 19122847.
Book Chapters
Example: Mansbach H. Sumatriptan: looking back and looking forward. In: Humphrey P, Ferari M, Olesen J (eds). The Triptans. New York: Oxford University Press, 2001;183–9.
4.0 Peer Review Process
We operate a double-blind peer-review process. All peer reviews are conducted within the Editorial Manager platform.
On submission, items submitted to the journal are assessed by the Editor-in-Chief to assess their suitability for inclusion. Items that fail a technical check are returned to the author at this stage for rectifying and are resubmitted. Manuscripts rejected at this stage are either insufficiently original, scientifically/statistically flawed, poor grammar/English language or deemed unsuitable/more suitable for another journal/outside the journal aims and scope.
The Review Editor, following consultation with the Editor-in-Chief, Section Editors and/or a member of the Editorial Board, sends the manuscript for peer review. All peer reviews are conducted independently, treated confidentially and are double-blinded. We require a minimum of two independent peer reviews but will seek a third review where there are conflicting reports. Original research manuscripts will always require an additonal review from a Statistical Editor.
The peer reviewers are selected on the basis of their expertise in the article subject matter and have no conflicts of interest. Reviewers should decline to review if a potential conflict of interest is present. Peer reviewers are not part of the editorial staff and operate independently from the article. Editorial staff employed by Vascular and Endovascular Review (VER), editors-in-chief, guest editors and editorial board members, will not handle manuscripts where a potential conflict of interest or competing interest exists and will be excluded from the peer-review process.
Editorial members and guest editors may submit to the Journal and must declare this. Their status has no bearing on the editorial considerations given during the peer review process. Articles authored by any in-house Editorial Board members will be treated with the same rigorous peer-review rules and handled avoiding any potential conflicts of interest. Where an author is a guest editor or editorial board member, this must be declared using one of the following statements in the submitted manuscript: [Author initials], is on the [insert journal name] editorial board, which did not affect the peer-review process. For multiple editorial board members: [Author initials], is a/an [insert role] and [Author initials] is on the [insert journal name] editorial board, which did not affect the peer-review process. [unless they have other COIs, in which case these shall be listed and added to the individual COIs]
The peer-review feedback is used to critically assess the quality of the article, to assess its suitability for inclusion in the journal and to ensure its credibility of scientific information.
Following review, manuscripts are either accepted without modification, accepted pending modification, or may require further revision, in which case the manuscripts may be returned to the author(s) to incorporate required changes, or may be rejected outright. Not all articles that are revised are subsequently accepted. The Editor-in-Chief reserves the right to accept or reject any proposed amendments. The Editors will not consider papers previously rejected by the journal.
Once the authors have revised a manuscript in accordance with the reviewers’ comments, the manuscript is returned to the reviewers to ensure the revised version meets their quality expectations. Once approved, the manuscript is sent to the Editor-in-Chief for final approval prior to publication. We aim to complete the peer review process with the average time from submission to the first decision within 5 weeks and submission to a final decision within 9 weeks.
It is our aim to ensure authors are notified of any rejection or retraction as soon as possible. An editor can reject an article at any time before publication, including after acceptance if there are concerns over the work. In the event that a journal is no longer published, access to all articles will be available via alternative platforms, such as PubMed Central, ESCI or Scopus.
5.0 Data Sharing Policy
Vascular and Endovascular Review (VER) is committed to an open science landscape, removing barriers from the sharing of research and the underlying data. This facilitates openness, transparency and reproducibility of research. Vascular and Endovascular Review (VER) is open access, and we encourage our authors to share their research data. Research data refers to the information gathered, reviewed, analysed, generated or created and can be presented in a variety of formats including numerical, descriptive, aural, or visual. We encourage the authors to:
- Share your research data in a relevant public data repository, where this does not violate the protection of human subjects or other valid subject privacy concerns.
- Include a data availability statement (DAS) that links to your data. Where the data cannot be shared, you should confirm why it is not possible to share the data within this statement.
- Cite the data in your research.
A recent study has found that citations can be increased by up to 25% for articles that share their data in a repository (Colavizza 2020). As our journals operate under a double-blind peer-review process, if sharing your data, you will need to use a repository that includes an option to preserve your anonymity.
Authors are encouraged to share their data but not required to. The decision to publish will not be affected by whether or not the authors share their research data.
5.1 Data Repositories
We advise authors to speak to your institutional librarian, funder or colleagues for guidance on choosing a repository that is relevant to your discipline. Alternatively, some useful resources for searching for a suitable repository are FAIRsharing and re3data.org, which provide a list of certified data repositories. Some general repositories that are not subject-specific include:
5.1 Data Repositories
We advise authors to speak to your institutional librarian, funder or colleagues for guidance on choosing a repository that is relevant to your discipline. Alternatively, some useful resources for searching for a suitable repository are FAIRsharing and re3data.org, which provide a list of certified data repositories. Some general repositories that are not subject-specific include:
5.2 Data Availability Statement
As per the ICMJE recommendations data sharing statements should include:
- whether individual de-identified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer);
- what data, in particular, will be shared;
- whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.);
- when the data will become available and for how long;
- by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).
The table below provides some template statements that you may use or adapt. You can find further guidance on how to compose this statement on the ICMJE recommendations website.
In order to be compliant with open access funder policies, from 01 April 2022, original research must include a Data Access Statement, even where there are no data associated with the article or the data are inaccessible. Please choose an appropriate statement from the list below to accompany your submission:
| Availability of Data | Template Statement |
|---|---|
| Data is openly available in a public repository (DOI provided) | The data that support the findings of this study are openly available in [repository name e.g “figshare”] at http://doi.org/[doi], reference number [reference number]. |
| Data openly available in a public repository (no DOI provided) | The data that support the findings of this study are openly available in [repository name] at [URL], reference number [reference number]. |
| Data derived from public domain resources | The data that support the findings of this study are available in [repository name] at [URL/DOI], reference number [reference number]. These data were derived from the following resources available in the public domain: [list resources and URLs] |
| Embargo on data due to commercial restrictions | The data that support the findings will be available in [repository name] at [URL / DOI link] following an embargo from the date of publication to allow for commercialization of research findings. |
| Data available on request due to privacy/ethical restrictions | The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. |
| Data subject to third party restrictions | The data that support the findings of this study are available from [third party]. Restrictions apply to the availability of these data, which were used under license for this study. Data are available [from the authors / at URL] with the permission of [third party]. |
| Data available on request from the authors | The data that support the findings of this study are available from the corresponding author upon reasonable request. |
| Data sharing not applicable – no new data generated | Data sharing is not applicable to this article as no new data were created or analyzed in this study. |
| Author elects to not share data | Research data are not shared. |
| Data available in article or its supplementary material | The data that supports the findings of this study are available in the article [and/or] the supplementary material of this article. |
| Data sharing not applicable – no new data generated, or the article describes entirely theoretical research | Data sharing not applicable to this article as no datasets were generated or analysed during the current study. |
| Non-digital Data | Non-digital data supporting this study are curated at [insert location]. |
5.3 Data Citation
Vascular and Endovascular Review (VER) supports the Force 11 Data Citation Principles, as such all publicly available datasets must be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI) using the following format and in line with the Vascular and Endovascular Review (VER) reference style:
[dataset]* Authors, Year, Title, Publisher (repository or archive name), accession number/DOI * The [dataset] tag will help us identify and tag the correct citation, but this will be removed prior to publication.
We protect an individual’s data and will not publish any patient data that might identify an individual without their written consent.
6.0 Manuscript Acceptance
6.1 Proofs
6.2 Information for Authors
6.3 Tips for Increasing Visibility and Impact
As the number of research articles being published each year continues to grow, it is important to maximise your articles’ visibility and those published in journals that you are on the editorial board for. This is especially important for encouraging people to read and cite your articles.
Vascular and Endovascular Review (VER) is published on a gold open access basis and are freely available to readers, making them accessible and easy to share and promote. Here are some tips for encouraging citations to your articles and those published in your journals.
Tips for Authors
Before Publication
- Maximise search engine optimisation (SEO) by including keywords in your title and abstract.
- Add section/ subheadings with keywords to the different sections of your article.
- Don’t be afraid to repeat keywords or phrases, as this will increase the likelihood of your article being placed higher in search engine results – just ensure that your repetition is not excessive.
- Collaborating with co-authors and combining networks will increase the visibility, reach and potential citations to your article.
- Ensure your author name is accurate and consistent across articles, as this makes it easier for readers to find all of your published work. For common names to avoid any confusion, use a research identifier, such as an ORCID.
- Cite your previous articles in new articles that you are writing where they are relevant.
After Publication
- Share a link to your article on social media (including Twitter, LinkedIn, Facebook, Academia.edu, ResearchGate, Mendeley) and on your institution profile page.
- Send a copy of your article colleagues.
- Add a copy of your article to your institutional repository.
- Network and attend key conferences and events and talk about your research.
- When presenting at conference and events, refer to any of your relevant previously published articles.
Tips for Editors and Board Members
- Promote the journal by including relevant journal articles on your reading lists if in a teaching role.
- Cite relevant journal articles in articles you are currently writing.
- When presenting at key conferences and events refer to relevant articles from the journal in your slides.
- Networking is key to building relationships and increasing journal awareness within the community. Not only will it attract submissions, readers and citations but it will also help with finding reviewers and potential editorial board members.
- Ensure that your review process is as efficient and effective as possible. Quick turnaround times will keep authors happy and increase the opportunity for the articles to make an impact.
- Publish regular special focus collections that address key/hot topics within the community and will generate interest.
6.4 Copyright, Permissions, Open Access and Funding
CCBYNC
Articles published in our Journals are gold open access, which means the version of record (VoR) is freely available, immediately upon publication, without charge, and allows users to read, download, copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
The author retains all non-commercial rights and Vascular and Endovascular Review (VER) retains all commercial rights (unless otherwise stated) for articles published under the Creative Commons Attribution Non-commercial CC-BY-NC 4.0 license.
After your manuscript is accepted the corresponding author will be asked to sign a mandatory publishing agreement to grant us permission to publish the manuscript under these terms.
6.5 Author Fees
To support open-access publication costs, Vascular and Endovascular Review (VER) charges an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper, as follows:
| Content-type | Fee | ||
| Indexed Journal (ESCI/PubMed) | Indexed Journal (Scopus/DOAJ) | Non-indexed Journal | |
| Article (Review/Original Research) | £1,500 | €1,770 | $1,970 | £1,355 | €1,600 | $1,780 | No fee (until 31 Dec 2023) |
| Case Report | £1,125 | €1,329 | $1,478 | £1,016 | €1,199 | $1,335 | No fee (until 31 Dec 2023) |
| Editorial | No fee | No fee | No fee |
| Expert Opinion | £1,125 | €1,329 | $1,478 | £1,016 | €1,199 | $1,335 | No fee (until 31 Dec 2023) |
| Letter | No fee | No fee | No fee |
| Meta-analysis | £1,125 | €1,329 | $1,478 | £1,016 | €1,199 | $1,335 | No fee (until 31 Dec 2023) |
*Prices updated: 31.03.22.
From 01 April 2022, we offer the option of publication under the CC-BY license for UKRI and Wellcome Trust-funded submissions. An article publication charge of £1,750 | €2,069 | $2,299 applies. Authors who wish to use this option must indicate this upon submission by selecting the correct funding option in the submission system.
Submissions from the UK will be subject to VAT. A VAT registration number should be supplied if applicable. If you are not registered for VAT, your invoice will still have VAT added.
After manuscript acceptance, the corresponding author will be contacted, and an invoice will be sent. Accepted articles will not be published until payment has been received.
6.6 Misconduct and malpractice
We take reasonable steps to identify and prevent the publication of papers where misconduct has occurred. In no case shall we as the publisher or our editors encourage or knowingly allow such misconduct to take place to published and unpublished papers.
Our journals use similarity checking software to detect unoriginal material and to avoid plagiarism. Where duplication is highlighted, the concerns will be raised with the author.
We do not permit the manipulation of research data through data falsification or data fabrication. Where data falsification or fabrication is suspected, the concerns will be raised with the author.
We reserve the right to reverse decisions to accept a submission where we believe our editorial policies have been infringed and papers suspected of misconduct will not be considered for publication. We reserve the right to inform the author’s co-authors and/or institution/regulatory body when such instances occur.
6.7 Errors, Omissions and Retractions
We take strive to ensure the academic integrity of our journals and to ensure that all content is reproduced correctly. However, we cannot guarantee the accuracy, adequacy or completeness of the information and cannot be held responsible for any errors or omissions, or for the results obtained from the use thereof. Occasionally circumstances may arise were an article is published that must later be retracted or removed. We commit to retract, correct and apologise for any inaccuracies or misleading statements with due prominence through errata which are issued as needed. Any errors should be reported to the journal’s Managing Editor. In all cases, our archives at The British Library and the Agency for Legal Deposit Libraries retain all versions.
6.8 Advertising
Advertising is not permitted to influence editorial decisions. Advertisements cannot be carried by the journal that juxtapose editorial content on the same product. Adverts may appear at the front and back of a journal (never within text). Misleading adverts may be refused.
6.9 Complaints & Appeals
Any complaints should be first directed to the Editorial Office/Managing Editor of the Journal in writing. If they are the subject of the complaint, please raise this with the Publishing Director. We as the Publisher will aim to deal with any complaints or allegations of misconduct as appropriately and as swiftly as possible. If not resolved satisfactorily, any complaints can be passed to the overseeing body or ombudsmen where one exists. Complaints may be referred to COPES within six months if it cannot be resolved through the journal’s complaints procedure and only if it pertains to procedural complaints rather than editorial content.
6.10 Reprints
Reprints of all published articles are available to authors, institutions and commercial organisations. Reprints are published as they appear in the journal unless a correction is to be added. Please contact Rob Barclay at editor@verjournal.com.
7.0 Information for Editors
7.1 Responsibilities of the Editorial Board
The Editor-in-Chief/Deputy Editor-in-Chief is appointed by the Publisher and/or Society (if a society-owned journal) as an agent and serves at the pleasure of the Publisher/Society. The Editor-in-Chief agrees to assist in a variety of aspects to support the journal, their responsibilities include (but are not limited to):
– Supporting the strategic development of the journal.
– Ensuring academic integrity and scientific expertise for the journal.
– Ensuring that accepted content is of the highest possible quality for publication in the journal.
– Making editorial decisions based on the quality and suitability of the journal and not for any political or financial gain.
– Evaluating new submissions to assess their suitability for peer review or immediate rejection, based on journal aims and scope as well as quality standards.
– Deciding on acceptance or rejection following peer review and providing suggestions for revision as appropriate.
– Acting as a final arbiter of the content.
– Suggesting potential authors and proposing titles/topics warranting inclusion or consideration in the journal.
– Ensuring the journal operates ethically and observes the policies set forth herein.
– Providing advice and guidance on editorial board structure and suggesting new members or membership renewal as appropriate.
– Promoting their editorship via appropriate channels to attract high-quality submissions, for example by passively raising the journal’s profile.
– Deputy EiC acting as EiC if required, e.g., for any submissions co-authored by the EiC.
Section editors, associate editors, regional editors, and editorial board members benefit the journal by helping to improve turnaround times, increase visibility and submissions and to help expand the scope of a journal. They agree to assist in a variety of aspects of running the journal, their responsibilities include (but are not limited to):
– Supporting the journal’s Editor-in-Chief to drive the overall quality of the journal.
– Providing scientific expertise for the journal.
– Submitting one review or expert opinion piece every two years.
– Contributing a minimum of two peer reviews per year on articles they feel qualified to review.
– Promoting the journal to attract high-quality submissions, for example by passively raising the journal’s profile and promoting their board membership where appropriate.
– Providing feedback and suggestions for the journal’s improvement and development.
– Suggesting relevant topics for consideration and potential authors that are within the aims and scope of the journal.
– Attend an annual board meeting so that members can be kept abreast of key journal developments and performance, but this is not compulsory.
Editorial Board members are regularly rotated (ideally once every two to three years) and as a Publisher, we encourage diversity in all areas of our editorial boards (nationalities, geographical reach and gender).
Editors-in-Chief, Deputy Editors and Section Editors are selected via an external recruitment and interview process where we would advertise a vacant position on our website and advertise this directly to our cardiovascular community. Editorial Board members are selected based on their activity, knowledge, and research in the field. They should be leaders in research, forward-thinking academics who are reliable and respected in their field and well-positioned to add credit to the journal.
7.2 Soliciting Article Submissions
Submissions may be solicited from experts in the field from time to time. These are identified in conjunction with the Editor-in-Chief, editorial board and Managing Editor/Publisher to ensure solicited articles are of the highest quality and relevance.
To ensure the journal remains relevant, solicited content is identified based on emerging/hot topics by examining content presented at key conferences that offers new data to the research area, including any important unpublished studies. In addition, other journal publications are reviewed to identify key trials that may be suitable for summarising their impact on clinical practice in a review article.
For solicited submissions, high-profile, expert authors are identified through publication databases such as Web of Science and Dimensions and by recommendations from the Editor-in-Chief, senior editors and editorial board. Authors are solicited based on their research impact (citations, publishing activity, leaders in research, forward-thinking academics and experience within the field). Solicited authors should be reliable and respected in the research community.
Solicited submissions are still always subject to a rigorous double-blind peer-review process.
8.0 Information for Institutional Partnerships
We are keen to work with institutions, libraries, consortia and funders to support researchers with the publication of open-access research and to accelerate open-access publishing.
We offer fully open-access publishing agreements that enable institutions and funders to cover open-access costs for our journals.
– Provide bulk discounts on article processing charges (APCs).
– Reduce administration for authors paying and processing APCs.
– Enable authors to publish important research at no cost to themselves.
– Provide a simplified payment method.
Interested in partnering with us?
Please email to editor@verjournal.com.